Funded Awards – December 2018

Funded Awards
PI Agency Title
Eve Colson NIH/R01/Boston Medical Center Study of Attitudes and Factors Effecting PREterm infan…
Jennifer Ikle Endocrine Fellows Foundation Generation and analysis of a zebrafish model of KATP-d…
Mark Lowe NIH/R01 Admin Supp/University of Iowa Supplement – Consortium for the Study of Chronic Pancr…
Emily Mathews NIH/F32 Heat shock Protein Prenyalation in Malaria Parasites
Jessica Pittman Cystic Fibrosis Foundation Therapeutics, Inc./Seattle Children’s Hospital A Prospective Study to Evaluate Biological and Clinica…
Katie Plax SAMHSA SUPPLEMENT: Capacity Building Initiative for Substance…
Katie Plax SAMHSA SUPPLEMENT: HIV Prevention Navigator
Daniel Rosenbluth CFF WU Therapeutics Development Center
Kathleen Simpson CCF/Research Grant Distinction of Serum biomarkers in Heart Failure Betwe…
Gregory Storch HRSA/HRI, Inc. QI Contract Schlueter
Gregory Storch NIH/ICF Incorporated, LLC Youth Navigation Program
Kentaro Yomogida Rheumatology Research Foundation/Scientist Development Award Plasticity of Innate Lymphoid Cells and their Potentia…
Funded Awards
Funded Grants September 2021

PI Agency Title Megan Cooper NIH/ UG3/UH3/Baylor College of Medicine Safety and Efficacy of Itacitinib in treatment of JAK/STAT gain of function disorders Amjad Horani CDI Mechanisms of Primary Ciliary Dyskinesia Cynthia Ortinau Brain & Behavior Research Foundation Association of Parental Psychological Distress with Brain and Neurodevelopment in Congenital Heart …

Funded Awards
Funded Grants August 2021

PI Agency Title Fahd Ahmad NIH/CCHMC EMS for Children: Pediatric Emergency Care Applied Research Network (PECARN)  Jonathan Cooper NIH/R56 Characterizing and testing the efficacy of AAV-mediated gene therapy in a novel CRISPR/Cas9 generated sheepmodel of Cln1 disease. Jorge Di Paola NIH/R01/Ohio State University A Reversible Aptamer Based Therapeutic to Treat …

Funded Awards
Funded Grants July 2021

PI Agency Title Mohamed Abdelbaki EIF/The Hospital for Sick Children 3CI Study: Childhood Cancer Combination Immunotherapy. Phase 1b and Expansion Study of Nivolumab Combination Immunotherapy in Children, Adolescent and Young Adult (CAYA) Patients with Relapsed/Refractory Hypermutant Cancers Amy Armstrong Aflac Foundation/Children’s Healthcare of Atlanta A Maintenance Protocol of Sirolimus in …